Minimal Residual Disease Status, Outcomes in Patients with Multiple Myeloma

Posted by on September 19, 2016 2:44 pm
Categories: health

A new study examines the assessment of minimal residual disease in patients newly treated for multiple myeloma as a factor in survival outcomes.

Leave a Reply

Your email address will not be published. Required fields are marked *